1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1609522-33-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-111388
    SEL120-34A

    CDK Cancer
    SEL120-34A is a potent, selective, orally available, ATP-competitive CDK8 inhibitor, with IC50s of 4.4 nM and 10.4 nM for CDK8/CycC and CDK19/CycC, respectively, with antitumor activity.